Children with MPS III generally do not display overt features of the condition at birth.
Signs and symptoms of the disease typically begin to be recognized in early childhood, between 2- to 6-years-old, when the child starts missing developmental milestones.
The American Academy of Pediatrics suggests considering evaluation for inborn errors of metabolism (including MPS disorders) in children with neuromotor and global developmental delays.
Please consider ordering a urine MPS screening (non-sterile urine specimen) for your patients with developmental delay or a combination with any features listed below.
With the initiation of treatment trials, early diagnosis is key to giving children a lifeline to participate in clinical trials. We need your help identifying patients as early as possible.
- Transient Tachypnea Of Newborn
- Macrocephaly/J-Shaped Sella on Lateral Skull X-Ray
- Recurrent Ear/Sinus Infections
- Speech/Developmental Delays
- Significant Hyperactivity
- Autistic Symptoms
- Diarrhea/Chronic Loose Stool
- Poor Sleep
- Umbilical Hernia
- Progressive Intellectual Disability With Brain Atrophy
- Enlarged Liver/Spleen
- Coarsening Facial Features (prominent eyebrows)
- Hearing Loss (May Be Early)
- Loss Of Ambulation
- Loss Of Oral Feeding
- Early Death
Average Age at Diagnosis of Patients With Sanfilippo
|Sanfilippo Type||No. of Diagnoses+||Median Age (Range)++|
|Type A||31||3.5 (0.2-17.1)|
|Type B||17||3.5 (0.0-21.4)|
|Type C||3||10.7 (5.7-12.0)|
|Type D||4||3.1 (0.4-7.4)|